Polight ASA

Regulatory Filings • Nov 10, 2025

poLight ASA Receives Follow-on Purchase Order for TWedge® Wobulator Technical Samples for AR|MR Use from a Leading Consumer OEM

poLight ASA Receives Follow-on Purchase Order for TWedge® Wobulator Technical Samples for AR|MR Use from a Leading Consumer OEM

Tønsberg, Norway 10 November 2025 - poLight ASA (OSE: PLT) today announced

that the company has received a follow-on purchase order worth NOK 880,000 to

supply its TWedge® wobulator technical samples to a leading consumer OEM for

an AR|MR display application.

"We are pleased to announce another follow-on purchase order for our TWedge®

wobulation technology," said Dr. Øyvind Isaksen, CEO of poLight ASA. "We see

strong and growing interest in this new concept, signaling that we are

addressing a critical need in the AR|MR market. Notably, most customers

evaluating TWedge® are also engaged with us on TLens®, making the integration

of both technologies within the same AR|MR product a promising prospect," said

Dr. Øyvind Isaksen, CEO of poLight ASA.

The delivery of TWedge® technical samples is expected to be completed in Q4

For further information, please contact:

Dr Øyvind Isaksen, CEO, poLight ASA: +47 90 87 63 98

About poLight ASA

poLight ASA (listed on the Oslo Stock Exchange: PLT) offers a patented,

proprietary tunable optics technology, starting with its first product, TLens®

which replicates "the human eye" experience in autofocus cameras used in

devices such as smartphones, wearables, barcode scanners, machine vision

systems and various medical equipment. poLight's TLens® enables better system

performance and new user experiences due to benefits such as extremely fast

focus, small footprint, no magnetic interference, low power consumption and

constant field of view. poLight is based in Tønsberg, Norway, with employees

in Finland, France, UK, US, China, Taiwan, Japan, and the Philippines. For

more information, please visit https://www.polight.com

(https://www.polight.com/)

This information has been submitted pursuant to the Securities Trading Act §

5-12 and MAR Article 17. The information was submitted for publication at

2025-11-10 07:30 CET.